Related Experiment Video
Updated: Dec 3, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Resolving the Disproportionate Left Ventricular Enlargement in Mitral Valve Prolapse Due to Barlow Disease: Insights
K Carlos El-Tallawi1, Danai Kitkungvan2, Jiaqiong Xu3
1Houston Methodist DeBakey Heart & Vascular Center, Houston, Texas, USA.
Insights
Prolapse volume contributes to total volume load in Barlow disease, explaining disproportionate left ventricular enlargement. Accounting for this volume load improves understanding of heart chamber remodeling.
Area of Science:
- Cardiology
- Cardiac Imaging
- Valvular Heart Disease
Background:
- Barlow disease features elongated mitral leaflets, leading to significant end-systolic prolapse volume.
- Left ventricular (LV) enlargement in Barlow disease can appear disproportionate to mitral regurgitation (MR) severity, raising concerns about Barlow cardiomyopathy.
Purpose of the Study:
- To investigate if total volume load, including transvalvular MR and prolapse volume, explains LV enlargement in Barlow disease.
- To compare MR, prolapse volume, and cardiac remodeling between bileaflet prolapse (BLP) and single leaflet prolapse (SLP) using cardiac magnetic resonance (CMR).
Main Methods:
- Cardiac magnetic resonance (CMR) was employed to assess patients with Barlow disease.
- Evaluated mitral regurgitation (MR), prolapse volume, and cardiac chamber remodeling in 157 patients (81 BLP, 76 SLP).
Main Results:
- Bileaflet prolapse (BLP) patients exhibited larger LV end-diastolic volume and prolapse volume despite similar transvalvular MR compared to single leaflet prolapse (SLP).
- Total volume load, incorporating prolapse volume, correlated better with LV end-diastolic volume in BLP patients.
- A multivariable model including prolapse volume provided a superior explanation for left heart chamber enlargement than MR alone.
Conclusions:
- Prolapse volume is a critical component of the total volume load in Barlow disease.
- This understanding helps explain the disproportionate LV enlargement observed in Barlow disease relative to MR severity.
Objectives:
This study hypothesized that left ventricular (LV) enlargement in Barlow disease can be explained by accounting for the total volume load that consists of transvalvular mitral regurgitation (MR) and the prolapse volume.
Background:
Barlow disease is characterized by long prolapsing mitral leaflets that can harbor a significant amount of blood-the prolapse volume-at end-systole. The LV in Barlow disease can be disproportionately enlarged relative to MR severity, leading to speculation of Barlow cardiomyopathy.
Methods:
Cardiac magnetic resonance (CMR) was used to compare MR, prolapse volume, and heart chambers remodeling in patients with Barlow disease (bileaflet prolapse [BLP]) and in single leaflet prolapse (SLP).
Results:
A total of 157 patients (81 with BLP, 76 with SLP) were included. Patients with SLP were older and more had hypertension. Patients with BLP had more heart failure. Indexed LV end-diastolic volume was larger in BLP despite similar transvalvular MR. However, the prolapse volume was larger in BLP, which led to larger total volume load compared with SLP. Increasing tertiles of prolapse volume and MR both led to an incremental increase in LV end-diastolic volume in BLP. Using the total volume load improved the correlation with indexed LV end-diastolic volume in the BLP group, which closely matched that of SLP. A multivariable model that incorporated the prolapse volume explained left heart chamber enlargement better than a MR-based model, independent of prolapse category.
Conclusions:
The prolapse volume is part of the total volume load exerted on the LV during the cardiac cycle and could help explain the disproportionate LV enlargement relative to MR severity noted in Barlow disease.
More Related Videos
07:42An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat
Published on: May 19, 2020
12:12Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
Published on: February 14, 2017
Related Concept Videos
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis I: Introduction
Mitral Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Mitral Regurgitation I: Introduction